A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Despite their chemical similarities, methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) produce differing neurochemical and behavioral responses in animals. In humans, individual studies of methamphetamine and MDMA indicate that the drugs engender overlapping and divergent effects; there are only limited data comparing the two drugs in the same individuals. This study examined the effects of methamphetamine and MDMA using a within-subject design. Eleven adult volunteers completed this 13-day residential laboratory study, which consisted of four 3-day blocks of sessions. On the first day of each block, participants received oral methamphetamine (20, 40 mg), MDMA (100 mg), or placebo. Drug plasma concentrations, cardiovascular, subjective, and cognitive/psychomotor performance effects were assessed before drug administration and after. Food intake and sleep were also assessed. On subsequent days of each block, placebo was administered and residual effects were assessed. Acutely, both drugs increased cardiovascular measures and “positive” subjective effects and decreased food intake. In addition, when asked to identify each drug, participants had difficulty distinguishing between the amphetamines. The drugs also produced divergent effects: methamphetamine improved performance and disrupted sleep, while MDMA increased “negative” subjective-effect ratings. Few residual drug effects were noted for either drug. It is possible that the differences observed could explain the differential public perception and abuse potential associated with these amphetamines. Alternatively, the route of administration by which the drugs are used recreationally might account for the many of the effects attributed to these drugs (i.e., MDMA is primarily used orally, whereas methamphetamine is used by routes associated with higher abuse potential).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00013-x · Cited by 448 · cited 1×
“also produce other prototypical stimulant effects, including increased heart rate and blood pressure, decreased food intake, and sleep disruptions (e.g., Comer et al. 2001; Vollenweider et al. 1998).”
Bedi, G., Hyman, D., & de Wit, H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.003 · Cited by 247 · cited 2×
“In general, these results are consistent with previous studies that have compared the acute effects of oral amphetamines with MDMA (e.g., Tancer and Johanson 2003; Johanson et al. 2006; Bedi et al. 2010).”
Camí, J., Farré, M., Mas, M., Roset, P. N., Poudevida, S., Mas, A., San, L., & de la Torre, R. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00010 · Cited by 234 · cited 1×
“Only a limited number of studies have compared the direct effects amphetamines with MDMA in the same research participants (Cami et al. 2000; Tancer and Johanson 2003; Johanson et al. 2006; Bedi et al. 2010).”
Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep
Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31811ed205 · Cited by 184
Self-citationMethamphetamine abuse and dentistry
Hamamoto, D., & Rhodus, N. (2009) · Oral Diseases · doi:10.1111/j.1601-0825.2008.01459.x · Cited by 166 · cited 1×
“For example, an impressively large human literature suggests that methamphetamine produces particularly pernicious long-term effects, including cognitive impairments (e.g., Baicy and London 2007), tooth decay (i.e., “meth mouth”: e.g., Hamamoto and Rhodus 2009 ), and psychological disturbances (e.g., Grelotti et al. 2…”
Tancer, M., & Johanson, C.-E. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00172-8 · Cited by 153 · cited 3×
“For example, both oral methamphetamine and MDMA increase wakefulness and euphoria and decrease food intake (e.g., Cami et al. 2000; Hart et al. 2002, 2003; Liechti et al. 2001; Tancer and Johanson 2003).”
The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance
Silber, B. Y., Croft, R. J., Papafotiou, K., & Stough, C. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0410-7 · Cited by 140 · cited 2×
“The finding that methamphetamine improved performance is consistent with our prediction and a growing database demonstrating enhanced performance on relatively simple tasks (Mohs et al. 1978; Hart et al. 2002; Silber et al. 2006).”
Bupropion SR worsens mood during marijuana withdrawal in humans
Haney, M., Ward, A. S., Comer, S. D., Hart, C. L., Foltin, R. W., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130000657 · Cited by 135 · cited 1×
“…with my sleep last night, " and a fill-in question in which participants were asked to estimate the number of hours they slept the previous night (Haney et al. 2001). were repackaged by the Pharmacy Department of the NYSPI by placing tablets into a white no. 00 opaque capsule and adding lactose…”
Self-citationJohanson, C.-E., Kilbey, M., Gatchalian, K., & Tancer, M. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.003 · Cited by 58
Comer, S. D., Haney, M., Foltin, R. W., & Fischman, M. W. (1996) · Psychopharmacology · doi:10.1007/bf02805973 · Cited by 26
Self-citation
Cited by
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar-Klosinski, B., Michel, Y., Brewerton, T. D., & Doblin, R. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112456611 · Cited by 376
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Dolder, P. C., Schmid, Y., Müller, F., Borgwardt, S., & Liechti, M. E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.82 · Cited by 247
“Additionally, MDMA has been shown to positively alter emotion processing (Bedi et al, 2010; Hysek et al, 2012,2014a; Kirkpatrick et al, 2012,2014; Schmid et al, 2014).”
Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans
Kirkpatrick, M. G., Francis, S. M., Lee, R., de Wit, H., & Jacob, S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.006 · Cited by 106
“…of euphoria (i.e., drug liking) as well as ratings of sociability such as feelings of friendliness, playfulness, and insightful, consistent with previous reports (Tancer and Johanson, 2003; Bedi et al., 2009, 2010; Hysek and Liechti, 2012; Hysek et al., 2012b; Kirkpatrick et al., 2012, 2014).”
BackgroundResultSelf-citationThe effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants
Bershad, A. K., Miller, M. A., Baggott, M. J., & de Wit, H. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116663120 · Cited by 106
Schenk, S., & Highgate, Q. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15348 · Cited by 48
“…(3) continuing to use MDMA despite adverse consequences (Cottler et al.,. ,2001, 2009; Yen & Hsu, 2007), (4) tolerance to the positive effects (Kirkpatrick et al., 2012; Parrott, 2005; Peroutka et al., 1988; Yen & Hsu, 2007) and (5) development of withdrawal symptoms (Curran & Travill, 1997;…”
Background
Metadata
- Authors
- Kirkpatrick, M. G., Gunderson, E. W., Perez, A. Y., Haney, M., Foltin, R. W., & Hart, C. L.
- Venue
- Psychopharmacology
- Published
- 2011-06-30
- Volume
- 219
- Issue
- 1
- Pages
- 109-122
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2050392483
- Cited by
- 120
- References
- 10
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. https://app.cochat.ai/papers/10.1007/s00213-011-2383-4
- The paper
- Kirkpatrick, M. G., Gunderson, E. W., Perez, A. Y., Haney, M., Foltin, R. W., & Hart, C. L. (2012). A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology. https://doi.org/10.1007/s00213-011-2383-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.